CBLL Ceribell Inc.

Price (delayed)

$23.62

Market cap

$906.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.76

Enterprise value

$895.74M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 27

Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly ...

Highlights
The gross profit has increased by 33% year-on-year and by 9% since the previous quarter
Ceribell's revenue has increased by 32% YoY and by 7% from the previous quarter
The EPS has dropped by 83% year-on-year and by 8% since the previous quarter
Ceribell's net income has decreased by 34% YoY and by 9% from the previous quarter

Key stats

What are the main financial stats of CBLL

CBLL stock price

How has the Ceribell stock price performed over time
Intraday
-2.6%
1 week
-3.59%
1 month
-2.4%
1 year
95.69%
YTD
7.71%
QTD
21.44%

Financial performance

How have Ceribell's revenue and profit performed over time
Revenue
$101.96M
Gross profit
$90.65M
Operating income
-$69.97M
Net income
-$66M
Gross margin
88.9%
Net margin
-64.7%
Ceribell's operating income has decreased by 35% YoY and by 8% QoQ
Ceribell's net income has decreased by 34% YoY and by 9% from the previous quarter
The gross profit has increased by 33% year-on-year and by 9% since the previous quarter
Ceribell's revenue has increased by 32% YoY and by 7% from the previous quarter

Price vs fundamentals

How does CBLL's price correlate with its fundamentals

Growth

What is Ceribell's growth rate over time

Valuation

What is Ceribell stock price valuation
P/E
N/A
P/B
6.98
P/S
8.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.78
The EPS has dropped by 83% year-on-year and by 8% since the previous quarter
The P/B is 56% above the last 4 quarters average of 4.6
The equity has declined by 25% year-on-year and by 9% since the previous quarter
Ceribell's revenue has increased by 32% YoY and by 7% from the previous quarter
CBLL's price to sales (P/S) is 26% higher than its last 4 quarters average of 7.2

Efficiency

How efficient is Ceribell business performance
CBLL's ROIC is up by 29% YoY but it is down by 16% from the previous quarter
The ROA has contracted by 25% YoY and by 16% from the previous quarter
Ceribell's return on equity has decreased by 18% QoQ but it has increased by 7% YoY
The return on sales has declined by 2.6% year-on-year and by 2.1% since the previous quarter

Dividends

What is CBLL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CBLL.

Financial health

How did Ceribell financials performed over time
CBLL's quick ratio is down by 33% year-on-year and by 13% since the previous quarter
CBLL's current ratio is down by 31% year-on-year and by 12% since the previous quarter
The debt is 83% smaller than the equity
The debt to equity rose by 31% year-on-year and by 6% since the previous quarter
The equity has declined by 25% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.